Anthony D'andrea, MD
Colon & Rectal Surgery · Galveston, TXNPI 1497149637
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,500 of the $10,081 with a category attached, or 64.5%. Intuitive Surgical accounts for 87.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $7,088 and has fallen 96.3% since, to $259 in 2025.
Across 29 payments — averaging $347.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$9K
- Stryker$559
- Fujifilm Healthcare Americas Corporation$305
- THD America, Inc.$136
- Hollister Incorporated$115
- Solventum Corporation$44
- plus $65 from 2 others
What the payments were for
- Travel & lodging$2,34323%
- Food & beverage$1,22912%
- Education$6,50064%
- Gifts$90%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 18 | $8,857 |
| Stryker | 4 | $559 |
| Fujifilm Healthcare Americas Corporation | 2 | $305 |
| THD America, Inc. | 1 | $136 |
| Hollister Incorporated | 1 | $115 |
| Solventum Corporation | 1 | $44 |
| Monaghan Medical Corporation | 1 | $38 |
| Northgate Technologies, Inc. | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$6,500
- Da Vinci Surgical System$2,216
- 1788$389
- FUJIFILM$305
- NEW IMAGE$115
- SPY-PHI SYSTEM$102
How this compares
$10,081 in reported general payments places this provider in the 70th percentile of 200 colon & rectal surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 26 | $434 |
| Neomycin Sulfate | 15 | $81 |
| Metronidazole | 20 | $53 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Galveston
- Pamela DaherGalveston$14K
- Thiru LakshmanAustin$756K
- Diego Marines CopadoHouston$462K
- Bidhan DasSugar Land$350K
- Christopher de JesusSan Antonio$201K
- Farshid AraghizadehFort Worth$181K
- Jefferson HurleyIrving$163K
- Erik AskenasyHouston$142K
- Eric HaasHouston$140K
- Robert JacobsonDallas$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.